Obsidian Therapeutics obsidiantx.com


Public list: Cancer Therapeutics (1133) Google In Healthcare (60)

Obsidian Therapeutics is developing next-generation cell and gene therapies with pharmacologic operating systems. It creates adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs. It improves on the current generation of cell therapies by: driving transplanted cells into the host immune system with proliferative singals, potentially reducing the need for toxic preconditioning of patients; prolonging the lives...Show all

Obsidian Therapeutics is developing next-generation cell and gene therapies with pharmacologic operating systems. It creates adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active...Show all

Company (Alive / Active)

Phone:

Fax:

1030 Massachusetts Avenue
Suite 400
Cambridge, 02138
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Obsidian Therapeutics $49.5M Dec 6, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Obsidian Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)